Skip to main content
Premium Trial:

Request an Annual Quote

NimbleGen Acquires UT Southwestern Spin-off Light Biology

NEW YORK, March 9 (GenomeWeb News) - NimbleGen Systems of Madison, Wis., has acquired Light Biology, a microarray technology company spun out of the University of Texas Southwestern in 2001.

Financial terms of the acquisition were not provided.

Light Biology was founded to commercialize a microarray fabrication technique developed by Harold "Skip" Garner, a professor of biochemistry and internal medicine at UT Southwestern. The method, called Digital Optical Chemistry, uses Texas Instruments' Digital Light Processing technology to manufacture DNA microarrays. According to Light Biology, the DOC process is quicker and more cost effective than previous microarray manufacturing methods, and will enable researchers to create customized arrays "in a matter of hours."

NimbleGen has acquired all of Light Biology's assets and patent rights to the DOC technology. As part of the acquisition agreement, Garner will join NimbleGen's scientific advisory board.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.